Literature DB >> 15831521

Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor.

Wendong Huang1, Jun Zhang, Michele Washington, Jun Liu, John M Parant, Guillermina Lozano, David D Moore.   

Abstract

The constitutive androstane receptor (CAR, NR1I3) is a central regulator of xenobiotic metabolism. CAR activation induces hepatic expression of detoxification enzymes and transporters and increases liver size. Here we show that CAR-mediated hepatomegaly is a transient, adaptive response to acute xenobiotic stress. In contrast, chronic CAR activation results in hepatocarcinogenesis. In both acute and chronic xenobiotic responses, hepatocyte DNA replication is increased and apoptosis is decreased. These effects are absent in CAR null mice, which are completely resistant to tumorigenic effects of chronic xenobiotic stress. In the acute response, direct up-regulation of Mdm2 expression by CAR contributes to both increased DNA replication and inhibition of p53-mediated apoptosis. These results demonstrate an essential role for CAR in regulating both liver homeostasis and tumorigenesis in response to xenobiotic stresses, and they also identify a specific molecular mechanism linking chronic environmental stress and tumor formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831521     DOI: 10.1210/me.2004-0520

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  100 in total

1.  Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.

Authors:  Ryota Shizu; Makoto Osabe; Lalith Perera; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

2.  Liver-specific ablation of Krüppel-associated box-associated protein 1 in mice leads to male-predominant hepatosteatosis and development of liver adenoma.

Authors:  Karolina Bojkowska; Fabio Aloisio; Marco Cassano; Adamandia Kapopoulou; Francesca Santoni de Sio; Nadine Zangger; Sandra Offner; Cristina Cartoni; Charles Thomas; Simon Quenneville; Kai Johnsson; Didier Trono
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.

Authors:  Zhipeng Meng; Xiaoqiong Wang; Yichao Gan; Yunfeng Zhang; Hong Zhou; Carl Van Ness; Jun Wu; Guiyu Lou; Hua Yu; Chao He; Rongzhen Xu; Wendong Huang
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

5.  Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor.

Authors:  Wenwei Lin; Lei Yang; Sergio C Chai; Yan Lu; Taosheng Chen
Journal:  Eur J Med Chem       Date:  2015-12-15       Impact factor: 6.514

6.  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism.

Authors:  E S Tien; M Negishi
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

7.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

8.  Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.

Authors:  Jennifer M Phillips; Jay I Goodman
Journal:  Toxicol Sci       Date:  2009-02-20       Impact factor: 4.849

Review 9.  The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

Authors:  Bryan Mackowiak; Jessica Hodge; Sydney Stern; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2018-05-14       Impact factor: 3.922

10.  Effects of 4-vinylcyclohexene diepoxide on peripubertal and adult Sprague-Dawley rats: ovarian, clinical, and pathologic outcomes.

Authors:  F Salih Muhammad; Amanda K Goode; Nancy D Kock; Esther A Arifin; J Mark Cline; Michael R Adams; Patricia B Hoyer; Patricia J Christian; Scott Isom; Jay R Kaplan; Susan E Appt
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.